Artificial intelligence (AI) is already changing the landscape of medicine, enhancing tried and true diagnostic tools. And ulcerative colitis (UC), a type of inflammatory bowel disease (IBD), is just one condition for which researchers are making impressive inroads into better predicting disease outcomes, flares, and complications, as well as identifying more targeted treatments, as they learn to harness AI’s technological might.
It’s early days, definitely, with scientists only beginning to grasp the scope of AI’s abilities in the medical arena for this condition. However, one way that AI could soon change UC care specifically is with the gold standard screening procedure for this disorder, the colonoscopy, which is used to recognize the red flags of UC. That includes screening for colon cancer, a type of cancer that people with UC are at a higher risk of developing.